NDC 52276-312 – Carbaglu

Carglumic Acid 200 mg/1 · Tablet, For Suspension · Oral

Human Prescription Drug

Product NDC52276-312

Product details

Brand name
Carbaglu
Generic name
Carglumic Acid
Labeler
Recordati Rare Diseases
Dosage form
Tablet, For Suspension
Route
Oral
Marketing category
NDA · NDA022562
Marketed since
March 18, 2010
Listing expires
December 31, 2026
Pharmacologic class
Carbamoyl Phosphate Synthetase 1 Activator

Active ingredients

Uses, dosage, side effects and warnings for Carbaglu →

Package NDC codes (2)

Package NDCDescriptionSince
52276-312-055 TABLET, FOR SUSPENSION in 1 BOTTLE (52276-312-05)Mar 18, 2010
52276-312-6060 TABLET, FOR SUSPENSION in 1 BOTTLE (52276-312-60)Mar 18, 2010